Targeted Retention of Cationic Liposomes at the Inflamed Blood–Brain Barrier by Incorporating Mesenchymal Stem Cell Membrane
A biomimetic strategy is developed to enhance inflamed BBB‐targeting gene delivery using cationic hybrid nanovesicles derived from mesenchymal stem cell membranes, named P(ML), offering potential therapeutic applications for ischemic stroke and other BBB‐related disorders.